<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01804907</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00032846</org_study_id>
    <nct_id>NCT01804907</nct_id>
  </id_info>
  <brief_title>Feasibility of Non-pharmacological Insomnia Therapy in People Living With HIV</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To establish with a prospective randomized placebo-controlled study the feasibility of
      allied-health personnel-administered cognitive behavioral insomnia therapy (CBTI) as a means
      of improving HIV/AIDS treatment adherence.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep Efficiency</measure>
    <time_frame>Week 1, 2,3, and 4</time_frame>
    <description>Patients evaluated weekly for change in sleep efficiency.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence to HAART</measure>
    <time_frame>Week 1, 2,3, and 4</time_frame>
    <description>Evaluated once weekly for changes in medication adherence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>Week 1, 2,3, and 4</time_frame>
    <description>Changes in reported fatigue levels measured weekly, via the Paper Fatigue Scale (PFS), and the HIV-Related Fatigue Scale (HRFS).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Insomnia</condition>
  <condition>Sleep Efficiency</condition>
  <arm_group>
    <arm_group_label>CBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cognitive Behavioral Therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Behavioral Modification</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Standard sleep hygiene education/desensitization therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
    <arm_group_label>CBT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral Modification</intervention_name>
    <arm_group_label>Behavioral Modification</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  provide documentation of HIV seropositivity, and have been on current HAART (Highly
             Active AntiRetroviral Therapy) or antiretroviral regimen without any foreseeable
             reason to discontinue the HAART during the course of the study;

          -  males or females age 18-75 years of age;

          -  â‰¥3 month history of insomnia meeting standard psychiatric criteria for insomnia based
             on DSISD;

          -  sleep onset latency (SOL) and/or wake after sleep onset (WASO) greater than 30
             minutes, with a corresponding sleep time of less than 6.5 hours at least 3 nights per
             week (as measured by the 7-day sleep diary);

          -  be able to read, understand, and sign an informed consent form before entering into
             the study and must be willing to comply with all study procedures as well as to agree
             to participate for the entire study period.

        Exclusion Criteria:

          -  use of any medication with a significant effect on sleep/wake function within 5
             half-lives of baseline or during the study including hypnotics, over-the-counter sleep
             aides, sedating antidepressants or sedating anxiolytics;

          -  history or DSISD (Duke Insomnia Sleep Diagnostics) suggests sleep disorder other than
             insomnia (e.g., sleep apnea, narcolepsy, periodic leg movements, etc.), or have
             insomnia associated with circadian rhythm disturbances, such as night or rotating
             shift work or travel across more than four time zones in the 14 days before Initial
             Screening (Visit 1) or during the study;

          -  clinically significant unstable medical or psychiatric condition, or have any
             clinically significant abnormal finding in physical examination, neurological
             assessment, or vital signs, as determined by the Investigator;

          -  self reports typical consumption of more than five alcoholic beverages on a single day
             or greater than 14 alcoholic beverages weekly at Initial Screening (Visit 1);

          -  have used any investigational drug within 30 days or five half-lives (whichever is
             longer) prior to Initial Screening (Visit 1), or plans to use an investigational drug
             during the study;

          -  unable to give informed consent or comply with study procedures.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2013</study_first_submitted>
  <study_first_submitted_qc>March 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2013</study_first_posted>
  <last_update_submitted>April 17, 2015</last_update_submitted>
  <last_update_submitted_qc>April 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HAART adherence</keyword>
  <keyword>HIV</keyword>
  <keyword>Fatigue</keyword>
  <keyword>treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

